Pegylated Interferon Alfa 2a
VX07-950-108
Phase 3 mab completed
Quick answer
Pegylated Interferon Alfa 2a for Hepatitis C is a Phase 3 program (mab) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Hepatitis C
- Phase
- Phase 3
- Modality
- mab
- Status
- completed